login
login

Europe Daily Bulletin No. 13487

21 September 2024
SECTORAL POLICIES / Health
European Commission extends authorisation for Mpox vaccine to teenagers
Brussels, 20/09/2024 (Agence Europe)

On Friday 20 September, the European Commission announced that it had extended the authorisation of the Imvanex vaccine to adolescents aged 12 to 17. It is the only vaccine against monkeypox currently authorised in the EU, together with an antiviral treatment (Tecovirimat SIGA).

The authorisation comes after the European Medicines Agency (EMA) deemed the vaccine effective and safe for this age group. Imvanex was first authorised in the EU in 2013 to protect adults against smallpox....

Contents

Russian invasion of Ukraine
SECTORAL POLICIES
PRESENTATION OF THE ‘VON DER LEYEN II’ COMMISSION
SECURITY - DEFENCE
EXTERNAL ACTION
SOCIAL AFFAIRS - EMPLOYMENT
INSTITUTIONAL
ECONOMY - FINANCE - BUSINESS
EDUCATION - YOUTH - CULTURE - SPORT
NEWS BRIEFS